Insight into the Status of Plasma Renin and Aldosterone Measurement: Findings from 526 Clinical Laboratories in China

Overview

Journal Clin Chem Lab Med

Specialties Biochemistry
Pathology

Date 2024 Apr 30

PMID 38687473

Authors

Weiyan Zhou

Yuhang Deng

Wenjun Ma

Haijian Zhao

Kaijun Wang

Qian Zhang

Wei Gan

Wenxiang Chen

Jun Cai

Chuanbao Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: Accurate measurements of renin and aldosterone levels play an important role in primary aldosteronism screening, which is of great importance in the management and categorization of hypertension. The objective of this study is to investigate the current status of plasma renin and aldosterone measurements in China, which is achieved by analyzing the results of 526 clinical laboratories nationwide for three pooled fresh plasma samples derived from more than 2,000 patients.

Methods: Renin and aldosterone in three pooled plasma samples were measured four times in 526 laboratories employing various measurement systems. The inter- and intra-laboratory %CV were calculated and compared. To determine the source of the substantial inter-laboratory %CV, laboratories were categorized according to the measurement systems they are using, and both the inter- and intra-measurement-system %CV were calculated and compared.

Results: Regarding renin, the majority of laboratories use four primary commercial immunoassays. However, for aldosterone, in addition to commercial immunoassays, laboratory-developed liquid chromatography-tandem mass spectrometry (LC-MS) methods are also used by laboratories. The median values of intra-laboratory %CVs, intra-measurement-system %CVs, inter-laboratory %CVs, and inter-measurement systems %CVs varied between 1.6 and 2.6 %, 4.6 and 14.9 %, 8.3 and 25.7 %, and 10.0 and 34.4 % for renin, respectively. For aldosterone, these values ranged from 1.4 to 2.2 %, 2.5-14.7 %, 9.9-31.0 %, and 10.0-35.5 %, respectively.

Conclusions: The precision within laboratories and measurement systems for plasma renin and aldosterone measurements is satisfactory. However, the comparability between laboratories using different measurement systems remains lacking, indicating the long way to achieve standardization and harmonization for these two analytes.

References

Yin R, Yin L, Li L, Silva-Nash J, Tan J, Pan Z . Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review. J Hum Hypertens. 2021; 36(2):126-134. PMC: 8252986. DOI: 10.1038/s41371-021-00570-z. View

Funder J, Carey R, Mantero F, Murad M, Reincke M, Shibata H . The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5):1889-916. DOI: 10.1210/jc.2015-4061. View

Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F . Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017; 69(14):1811-1820. DOI: 10.1016/j.jacc.2017.01.052. View

Funder J . Primary Aldosteronism: Present and Future. Vitam Horm. 2019; 109:285-302. DOI: 10.1016/bs.vh.2018.10.006. View

Hundemer G, Curhan G, Yozamp N, Wang M, Vaidya A . Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2017; 6(1):51-59. PMC: 5953512. DOI: 10.1016/S2213-8587(17)30367-4. View

Young Jr W . Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2018; 285(2):126-148. DOI: 10.1111/joim.12831. View

Martin R, HAYSLETT J . Role of aldosterone in the mechanism of renal potassium adaptation. Pflugers Arch. 1986; 407(1):76-81. DOI: 10.1007/BF00580724. View

Vetter H, Vetter W . Regulation of aldosterone secretion in primary aldosteronism. Horm Metab Res. 1975; 7(5):418-24. DOI: 10.1055/s-0028-1093697. View

Giacchetti G, Opocher G, Sarzani R, Rappelli A, Mantero F . Angiotensin II and the adrenal. Clin Exp Pharmacol Physiol. 2010; 23 Suppl 3:S119-24. DOI: 10.1111/j.1440-1681.1996.tb03072.x. View

10.

Turcu A, Yang J, Vaidya A . Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022; 18(11):665-682. DOI: 10.1038/s41574-022-00730-2. View

11.

Reincke M, Bancos I, Mulatero P, Scholl U, Stowasser M, Williams T . Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021; 9(12):876-892. DOI: 10.1016/S2213-8587(21)00210-2. View

12.

Coulon C, Lotierzo M, Fesler P, Roubille C, Badiou S, Dupuy A . Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays. Clin Chem Lab Med. 2022; 60(11):1763-1771. DOI: 10.1515/cclm-2022-0576. View

13.

Giangrande C, Vaneeckhoutte H, Boeuf A, Lalere B, Hirtz C, Lehmann S . Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF). Clin Chem Lab Med. 2023; 61(7):1235-1244. DOI: 10.1515/cclm-2022-1250. View

14.

Taibon J, Santner T, Singh N, Ibrahim S, Babitzki G, Koppl D . An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of aldosterone in human serum and plasma. Clin Chem Lab Med. 2023; 61(11):1902-1916. DOI: 10.1515/cclm-2022-0996. View

15.

Stockl D, Reinauer H, Thienpont L, De Leenheer A . Determination of aldosterone in human serum by isotope dilution gas chromatography/mass spectrometry using a new heptafluorobutyryl derivative. Biol Mass Spectrom. 1991; 20(11):657-64. DOI: 10.1002/bms.1200201102. View

16.

Juutilainen A, Savolainen K, Romppanen J, Turpeinen U, Hamalainen E, Kemppainen J . Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism. Clin Chim Acta. 2014; 433:209-15. DOI: 10.1016/j.cca.2014.03.015. View

17.

Deng Y, Zhang C, Wang J, Zeng J, Zhang J, Zhang T . An Accurate Isotope Dilution Liquid Chromatography-Tandem Mass Spectrometry Method for Serum C-Peptide and Its Use in Harmonization in China. Ann Lab Med. 2023; 43(4):345-354. PMC: 9989529. DOI: 10.3343/alm.2023.43.4.345. View

18.

Little R, Wielgosz R, Josephs R, Kinumi T, Takatsu A, Li H . Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned. Clin Chem. 2017; 63(9):1447-1456. PMC: 5575958. DOI: 10.1373/clinchem.2016.269274. View